Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date30 Apr 2004 |
100 Clinical Results associated with Harbin Sanle Biological Engineering Co. Ltd.
0 Patents (Medical) associated with Harbin Sanle Biological Engineering Co. Ltd.
100 Deals associated with Harbin Sanle Biological Engineering Co. Ltd.
100 Translational Medicine associated with Harbin Sanle Biological Engineering Co. Ltd.